Literature DB >> 32240616

LNCRNA Gas5 suppression protected Hl-1 cells against hypoxia injury by sponging Mir-222-3p.

Jie He1, Henhua Dai1, Qian Zhao1, Jianshu Guo2, Chi Chen3.   

Abstract

Hypoxia may cause diseases in human beings. The up- or down- regulation of lncRNAs were identified to possess the ability to protect the myocardial cells from hypoxia injury. This study explored the role of lncRNA GAS5 in sodium Hydrosulfite Induced Hl-1 Cells in vitro. RT-qPCR was applied to measure the expressions of RNAs whereas the cell viability was detected with CCK-8. Luciferase report assay was performed to validate the binding between lncRNA GAS5 and miR-222-3p. The proteins regarding PI3K/AKT signaling were evaluated through western blot analysis. The results showed that the hypoxia could reduce cell viabilities and enhance the apoptosis. Meanwhile, the PI3K/AKT signaling pathway was suppressed as well. lncRNA GAS5 got expressed higher in hypoxic cells whereas the suppressed GAS5 was able to increase cell viabilities while inhibiting apoptosis. MiR-222-3p was the target gene of lncRNA as determined by the luciferase report assay and its expressions were low in hypoxic cells. The overexpressed miR-222-3p could promote proliferation and inhibit apoptosis. Then, the correlation of GAS5 and miR-222-3p was measured which showed that miR-222-3p could resume the functions of GAS5 in cell viabilities and apoptosis through protein regulation in PI3K and AKT signaling pathways.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Apoptosis; GAS5; Hypoxia; Myocardium; PI3K/AKT; Proliferation

Year:  2020        PMID: 32240616     DOI: 10.1016/j.yexmp.2020.104436

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  2 in total

Review 1.  GAS5‑mediated regulation of cell signaling (Review).

Authors:  Yang Zhou; Binghai Chen
Journal:  Mol Med Rep       Date:  2020-08-19       Impact factor: 2.952

2.  LncRNA LSINCT5/miR-222 regulates myocardial ischemia‑reperfusion injury through PI3K/AKT pathway.

Authors:  Xueying Tong; Jiajuan Chen; Wei Liu; Hui Liang; Hezhong Zhu
Journal:  J Thromb Thrombolysis       Date:  2021-06-28       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.